Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GE-148 (18F) PET Imaging for Localized Prostate Cancer
NCT01176513Phase 2Terminated
- Sponsor
- GE HealthCare
- Start
- Jul 2010
- Primary completion
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fluciclovine f 18 in prostate cancer (PCa), sponsored by GE HealthCare. Started Jul 2010; status: terminated.
02
Drugs
fluciclovine f 18
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT01176513.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01176513.